Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
Advertisement
Axcan Pharma Inc. announced the appointment of Steve Gannon as Senior Vice President and Chief Financial Officer (CFO) in order to enhance its senior financial team. This appointment will be effective April 3, 2006. Mr. Jean Vézina, formerly CFO, will continue to serve in the role of Vice President, Finance.
As Senior Vice President and CFO, Mr. Gannon will provide financial oversight and guidance of Axcan's operations and growth opportunities, and enhance the capabilities of the organization by working closely with the financial markets. Mr. Gannon brings extensive financial experience in corporate growth initiatives such as acquisitions, corporate alliances and partnerships within biotechnology and pharmaceutical companies. Mr. Gannon has held a number of senior financial roles in AstraZeneca and most recently, served as Chief Financial Officer of CryoCath Technologies Inc. Mr. Gannon received his Bachelor of Commerce from the University of Concordia, and his chartered accountant's designation (CA) in 1985.
Joining Axcan in December 1992, Jean Vézina has been instrumental in managing Axcan's financing activities through several rounds of private financing, as well as the Company's initial public offering in 1995 and the NASDAQ listing in 2000. He also implemented best practices in public company reporting, disclosure and financial control, and leads implementation of the Company's Sarbanes-Oxley compliance measures worldwide. Enhancement of the senior financial team, will allow him to concentrate fully on overall compliance to applicable legislation, regulations and policies and ensure the highest standard of internal controls.
Other news from the department people
